Trials / Recruiting
RecruitingNCT07033013
A Randomized, Double Blind, Placebo Controlled, Clinical Study to Examine the Benefits of an Oral Product in Panelists With Menopausal Symptoms Including Vasomotor Symptoms (VMS).
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Olly, PBC · Industry
- Sex
- Female
- Age
- 40 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
Randomized, Double-Blind, Placebo-Controlled, Single-Center Clinical Study with a Run-in Baseline, Daily Diary Log, and Validated Questionnaires (Greene GCS) with Oral Dietary Supplement
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Placebo | Placebo |
| DIETARY_SUPPLEMENT | Dietary Supplement with actives | Dietary supplement containing EstroG-100 and GABA |
Timeline
- Start date
- 2025-07-07
- Primary completion
- 2025-07-25
- Completion
- 2025-08-01
- First posted
- 2025-06-24
- Last updated
- 2025-07-16
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT07033013. Inclusion in this directory is not an endorsement.